Gouws Capital LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Buy |
2,855
+440
| +18% | +$81.7K | 0.29% | 33 |
|
|
2025
Q1 | $506K | Buy |
2,415
+60
| +3% | +$12.6K | 0.3% | 33 |
|
|
2024
Q4 | $418K | Hold |
2,355
| – | – | 0.29% | 32 |
|
|
2024
Q3 | $465K | Hold |
2,355
| – | – | 0.31% | 32 |
|
|
2024
Q2 | $404K | Buy |
2,355
+125
| +6% | +$21.4K | 0.29% | 31 |
|
|
2024
Q1 | $406K | Hold |
2,230
| – | – | 0.31% | 31 |
|
|
2023
Q4 | $346K | Sell |
2,230
-1,125
| -34% | -$174K | 0.28% | 34 |
|
|
2023
Q3 | $500K | Hold |
3,355
| – | – | 0.42% | 33 |
|
|
2023
Q2 | $452K | Buy |
3,355
+175
| +6% | +$23.6K | 0.37% | 34 |
|
|
2023
Q1 | $507K | Buy |
3,180
+320
| +11% | +$51K | 0.45% | 33 |
|
|
2022
Q4 | $462K | Sell |
2,860
-640
| -18% | -$103K | 0.44% | 34 |
|
|
2022
Q3 | $470K | Sell |
3,500
-215
| -6% | -$28.9K | 0.47% | 33 |
|
|
2022
Q2 | $569K | Hold |
3,715
| – | – | 0.54% | 32 |
|
|
2022
Q1 | $602K | Sell |
3,715
-15
| -0.4% | -$2.43K | 0.49% | 33 |
|
|
2021
Q4 | $505K | Buy |
+3,730
| New | +$505K | 0.41% | 37 |
|